Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide Plus Dexamethasone in Refractory/Relapsed B-Cell ALL
NCT01116193Phase 2Completed
- Sponsor
- Institut de Cancérologie Lucien Neuwirth
- Start
- Jan 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in B-cell acute lymphoblastic leukemia (B-ALL), sponsored by Institut de Cancérologie Lucien Neuwirth. Started Jan 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
B-cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT01116193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116193.